Related Experiment Video
Updated: Dec 15, 2025

12:08
Cultivate Primary Nasal Epithelial Cells from Children and Reprogram into Induced Pluripotent Stem Cells
Published on: March 10, 2016
11.6K
Single-Cell and Population Transcriptomics Reveal Pan-epithelial Remodeling in Type 2-High Asthma
Nathan D Jackson1, Jamie L Everman1, Maurizio Chioccioli2
1Center for Genes, Environment, and Health, National Jewish Health, Denver, CO 80206, USA.
Cell Reports
|July 9, 2020
Summary
Interleukin-13 (IL-13) drives mucus in type 2 high (T2H) asthma by altering airway cells. This remodeling causes mucus imbalance and impaired airway function, offering new therapeutic targets.
Area of Science:
- Pulmonary Medicine
- Immunology
- Cell Biology
Background:
- Type 2 cytokine-high (T2H) asthma involves airway mucus obstruction.
- The precise mechanisms of IL-13's role in T2H asthma pathobiology are not fully understood.
Purpose of the Study:
- To investigate the effects of IL-13 on human airway epithelial cells.
- To elucidate the cellular and molecular mechanisms underlying IL-13-driven airway remodeling in T2H asthma.
Main Methods:
- Utilized single-cell RNA sequencing to analyze IL-13 effects on human airway epithelial cell cultures.
- Compared transcriptional signatures in T2H asthma patients with healthy controls.
Main Results:
- IL-13 induces a distinct transcriptional state in each airway cell type.
- A universal mucus secretory program is activated, leading to metaplasia in secretory cells and ER stress/cell death in ciliated cells.
- The remodeled epithelium exhibits mucin imbalance, depleted innate immunity, and arrested mucociliary motion, mirroring T2H asthma signatures.
Conclusions:
- IL-13 orchestrates widespread epithelial remodeling in T2H asthma.
- Identified potential therapeutic targets for restoring normal airway epithelial function in T2H asthma.
Keywords:
GALARNA-seqair-liquid interfaceciliary beat frequencydiseaselungproteomicssecretomesingle cell sequencingtype 2 inflammation
